## Abstract The purpose of this study is to compare the profile of percutaneous coronary intervention (PCI) patients who receive abciximab versus eptifibatide, as well as to compare the effect of abciximab versus eptifibatide on hospital length of stay. Retrospective data were obtained from HCIA's
Impact of abciximab versus tirofiban on hospital length of stay for PCI patients
โ Scribed by Maureen J. Lage; Beth L. Barber; Patrick L. McCollam; Mohan Bala; Joel Scherer
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 65 KB
- Volume
- 52
- Category
- Article
- ISSN
- 1522-1946
- DOI
- 10.1002/ccd.1069
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The purpose of this study was to examine the total hospital costs associated with the receipt of abciximab versus tirofiban for percutaneous coronary intervention (PCI) patients. Hospital billing data for patients with a primary procedure of PCI was examined for the period of July 1998
Some Americans suffer a higher cancer incidence and mortality than those in mainstream American society, and, in general, do not enjoy the same health status. Black Americans, for example, have higher cancer incidence and lower survival rates than do white Americans. To date, there is no known genet